Prevención y Tratamiento de la Enfermedad Injerto Contra Huésped (EICH)
Prevention and Treatment of Graft-versus-Host Disease (GVHD) - Video in Spanish
English
Webinar
You are here
CAR T-cells in Non-Hodgkin Lymphoma, A Hopeful Option
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
COVID-19: Precautions, Vaccines and Treatments for Transplant Recipients
Learn how stem cell transplant recipients can best protect themselves against COVID-19, and newest treatment options available if you do get COVID-19.
Transplantation for Myelodysplastic Syndromes (MDS): Who, When and How
More than 60,000 people have myelodysplastic syndrome (MDS) in the U.S. Learn about the best treatment options.
GVHD Caregivers: Building Resilience for the Road to Recovery
Learn challenges and coping strategies for caregivers of patients with graft-versus-host disease.
COVID 19 Winter Update: What Transplant Recipients Need to Know
With cases of COVID-19 on the rise this winter, it's important to have the latest facts about your risk for getting a severe case of COVID-19.
Live Your Best Life: How to Manage Fatigue and Adapt Routines to Maximize Quality of Life with GVHD
Learn how occupational therapists can help you improve your quality of life.
The Scars You Can’t See Are the Hardest to Heal: Coping with the Impact of Graft versus Host Disease
Learn how Acceptance and Commitment Therapy can improve mental well-being.
CAR T-cell Therapy for Patients with Multiple Myeloma
CAR T-cell and other new drugs are expanding treatment options for patients with myeloma.
Acute Myeloid Leukemia: Increasing Complexity and Increasing Treatment Opportunities
Learn about the different types of acute myeloid leukemia (AML), how it is treated, and when transplant is the best option.
